Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Apr 4, 2020
Date Accepted: Jun 3, 2020

The final, peer-reviewed published version of this preprint can be found here:

Effects of a 12-Week Multifaceted Wearable-Based Program for People With Knee Osteoarthritis: Randomized Controlled Trial

Li LC, Feehan LM, Xie H, Lu N, Shaw C, Gromala D, Koehn C, Hoens A, English K, Tam J, Therrien S, Townsend A, Noonan G, Backman C

Effects of a 12-Week Multifaceted Wearable-Based Program for People With Knee Osteoarthritis: Randomized Controlled Trial

JMIR Mhealth Uhealth 2020;8(7):e19116

DOI: 10.2196/19116

PMID: 32618578

PMCID: 7367519

Effects of a 12-week Multifaceted Wearable-based Program for People with Knee Osteoarthritis: A Randomized Controlled Trial

  • Linda C Li; 
  • Lynne M Feehan; 
  • Hui Xie; 
  • Na Lu; 
  • Chris Shaw; 
  • Diane Gromala; 
  • Cheryl Koehn; 
  • Alison Hoens; 
  • Kelly English; 
  • Johnathan Tam; 
  • Stephanie Therrien; 
  • Anne Townsend; 
  • Gregory Noonan; 
  • Catherine Backman

ABSTRACT

Background:

Current guidelines emphasize an active lifestyle in the management of knee osteoarthritis (OA), but up to 90% of OA patients are inactive. We previously demonstrated that an 8-week physiotherapist (PT)-led counselling intervention, with the use of a Fitbit, improved step count and quality of life in people with knee OA, compared to a control.

Objective:

To examine the effect of a 12-week, multifaceted wearable-based program on physical activity and patient outcomes in people with knee OA.

Methods:

A randomized controlled trial with a delay-control design. The Immediate Group (IG) received group education, a Fitbit, access to FitViz (a Fitbit-compatible app), and 4 biweekly phone calls by a PT over 8 weeks. Participants then continued using Fitbit and FitViz independently up to Week 12. The Delay Group (DG) received a monthly e-newsletter. Participants were assessed in Week 13, 26 and 39. The primary outcome was time in daily moderate/vigorous physical activity (MVPA; in bouts of >10 mins) measured with a SenseWear Mini. Secondary outcomes included daily steps, time in purposeful activity and sedentary behaviour, Knee Injury & OA Outcome Score, Patient Health Questionnaire-9, Partners in Health Scale, Theory of Planned Behaviour Questionnaire; and perceived habitual behaviour.

Results:

We enrolled 51 participants (IG: n=26; DG: n=25). Compared to IG, DG accumulated significantly more MVPA time at baseline. The adjusted mean difference in MVPA was 13.1 mins/day (95% CI 1.6 to 24.5). A significant effect was also found in the perceived sitting habit at work (0.7; 95% CI 0.2 to 1.2) and at leisure (0.7; 95% CI 0.2 to 1.2). No significant effect was found in the remaining secondary outcomes.

Conclusions:

A multifaceted program with the use of a wearable device, an app and PT counselling improved physical activity in people with knee OA 4 weeks after the counselling component ended. Clinical Trial: ClinicalTrials.gov: NCT02585323


 Citation

Please cite as:

Li LC, Feehan LM, Xie H, Lu N, Shaw C, Gromala D, Koehn C, Hoens A, English K, Tam J, Therrien S, Townsend A, Noonan G, Backman C

Effects of a 12-Week Multifaceted Wearable-Based Program for People With Knee Osteoarthritis: Randomized Controlled Trial

JMIR Mhealth Uhealth 2020;8(7):e19116

DOI: 10.2196/19116

PMID: 32618578

PMCID: 7367519

The author of this paper has made a PDF available, but requires the user to login, or create an account.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.